Atticus Wealth Management, LLC Vista Gen Therapeutics, Inc. Transaction History

Atticus Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 18, 2021	SELL	$2.62 - $3.45 $1,813 - $2,387	-692 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$1.96 - $3.15 $3,920 - $6,300	-2,000 Reduced 74.29%	692 $2,000
Q1 2021 Apr 15, 2021	BUY	$1.89 - $2.96 $5,087 - $7,968	2,692 New	2,692 $6,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $672M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Atticus Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Atticus Wealth Management, LLC with notifications on news.